Phio Pharmaceuticals Reaches Milestone: Second Cohort Fully Enrolled in Phase 1b Dose-Escalating Clinical Study

newsmaker04 mins

Six Clinical Sites Across the U.S. Engaged in Phase 1b Study Phio Pharmaceuticals Corp. Completes Enrollment for PH-762 Trial Marlborough, Massachusetts–(Newsfile Corp. – November 19, 2024) – Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company exploring new pathways towards a cancer-free future, today announced it has completed the enrollment of its second patient…

Read More

Uncovering the Hidden Gems of Pfizer: A Strong Pipeline, Undervaluation, and Growth Potential Make for a Compelling Investment Opportunity

marketinsights03 mins

I upgrade Pfizer to “Strong Buy” due to its undervaluation, strong pipeline, and operational growth Pfizer’s Q3 FY2024 earnings Recently, Pfizer announced its Q3 FY2024 earnings, which showcased significant revenue and EPS growth. This positive performance was mainly driven by the success of their COVID-19 therapies and oncology products. Despite recent stock price declines, Pfizer’s…

Read More

Breaking News: Bitfinex Data Breach Affects 400,000 Customers – What You Need to Know!

marketinsights03 mins

Bitfinex Faces Data Breach Controversy with 400,000 Customers Affected The post Bitfinex, a major cryptocurrency exchange, faces turmoil following reports of a significant data breach. Bitfinex, a major cryptocurrency exchange, faces turmoil following reports of a significant data breach. Bitfinex, a major cryptocurrency exchange, faces turmoil following reports of a significant data breach. However, Tether’s…

Read More

Credit Suisse’s US Subsidiary Gets Slapped with $900K Fine by FINRA: A Tale of Institutional Forex Woes

financenews03 mins

FINRA Slams Credit Suisse with $900,000 Fine for Reporting Failures What Happened? The Financial Industry Regulatory Authority (FINRA) has imposed a censure and fine of $900,000 on Credit Suisse for reporting more than 9,000 late trades and hundreds of thousands of inaccurate TRACE reports. The ruling covers the period from November 2015 to March 2023….

Read More

Exploring the Impact of Robert F. Kennedy Jr. on the SEC’s Stance on Cryptocurrency

marketnews04 mins

Crypto vs SEC: Can Robert F. Kennedy Jr Influence SEC’s Approach to Crypto? Introduction Former Ripple director Sean McBride recently stirred the pot by calling out U.S. presidential candidate Robert F. Kennedy Jr. regarding what he perceives as corruption within the U.S. Securities and Exchange Commission (SEC). McBride’s message to Kennedy underscored the lack of…

Read More

“DLH Shares Fiscal 2025 First Quarter Results: A Heartfelt Look at the Company’s Performance”

marketnews04 mins

Navigating Challenges in Company’s Transformation Journey; Delivering Recent Wins and Growing Bid Pipeline to Improve Outlook for Organic Growth Introduction Embarking on a journey of transformation within a company is no easy feat. It requires dedication, perseverance, and a strategic outlook to navigate the challenges that arise along the way. However, by delivering recent wins…

Read More

Navigating the SEC’s Regulatory Landscape: The Impact on XRP, Dogecoin, Solana, and ETFs

newsit06 mins

The Importance of Regulated Futures Markets for Crypto ETF Approvals The SEC’s Focus on Regulated Futures Markets Over the past few years, the Securities and Exchange Commission (SEC) has placed a significant emphasis on regulated futures markets when considering approvals for cryptocurrency exchange-traded funds (ETFs). This focus on regulated futures markets stems from the SEC’s…

Read More